Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Alpine Immune Sciences

Biotech & Life Sciences · Seattle, United States · Founded 2015 · IPO 2015 Unicorn

Immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions

Valuation
$4.46B
Market cap · 2026
Revenue
$59M
Latest reported FY

Investors

3 investors on Alpine Immune Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Alpine BioVentures
OrbiMed
Frazier Healthcare Partners

Global footprint

Where Alpine Immune Sciences has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States93.6%
🇨🇦 Canada3.2%
🇮🇳 India3.2%
3 countries shown
Web traffic by country
370 monthly visits
across markets
🇺🇸 United States108.1%
Top 1 markets shown

Patent intelligence

$42M patent portfolio · 27 active families

Estimated portfolio value
$42M
0.93% of market cap · 48.8× smaller than top peer Ablynx ($2B)
27 active patent families
Where Alpine Immune Sciences innovates Molecular biologyS-nitrosoglutathione reductaseS-NitrosoglutathioneNitrosoGlutathione

Where Alpine Immune Sciences concentrates vs peers

Each axis is a top-10 topic across Alpine Immune Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Alpine Immune Sciences

An AI-synthesized read of the highest-engagement posts about Alpine Immune Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alpine Immune Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.